- Home
- / InterVenn BioSciences
InterVenn BioSciences
Total Funding
$244.4 M
InterVenn BioSciences Summary
Company Summary
- Overview
- InterVenn BioSciences (also known as Venn Biosciences Corporation) is a life sciences technology company that develops an AI-driven spectrometry platform. It offers GlycoKnow, a colon test that develops risk assessment test that uses glycopeptide and peptide biomarkers. The company provides treatment in the areas of cancer, autoimmunity, fibrosis, and neurodegeneration.
- Type
- Private
- Status
- Active
- Founded
- 2017
- HQ
- South San Francisco, CA, US | view all locations
- Website
- https://intervenn.com
- Cybersecurity rating
Table of Contents
Key People
Aldo Carrascoso, Co-Founder
Stephana Patton, Chief Legal Officer
Katherine Dalao, Senior Vice President of Operations, Quality & Regulatory
LocationsView all
4 locations detected
South San Francisco, CA HQ
United States
2 Tower Pl 5th Floor
Melbourne, VIC
Australia
Level 2 , 91-93 Victoria Parade
Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur
Malaysia
L3-E-11 Enterprise 4, Technology Park Malaysia, Lebuhraya Puchong -Sg. Bukit Jalil
Mandaluyong, NCR
Philippines
19th Floor, The Podium West Tower, 12 ADB Avenue, Ortigas Center